Ling Jian Meng has focused a number of his research efforts on the diagnosis and treatment of cancer. These include the development of various imaging techniques for tracking T-cells (a collaboration with Professor Ed Roy at UIUC), creating therapeutically-engineered neural stem cells for treating glioblastoma (a collaboration with Professor Michael Lesniak at Northwestern University), and the development and characterization of X-ray induced and nanoparticle-mediated cancer therapy.
Meng has substantial experience in developing high-performance gamma-ray sensors and advanced
radiological imaging techniques. Over the past 15 years, his research group has developed a wide range of SPECT, PET, and X-ray instrumentations with emphases on ultrahigh spatial resolution (sub-100um) and simultaneous (SPECT/MR, SPECT/CT) multi-modality imaging capabilities.
Meng received his PhD in Detector Physics from the University of Southampton in the United Kingdom. He is a Professor in the Department of Nuclear, Plasma, and Radiological Engineering, and has affiliate appointments in the Department of Bioengineering and the Beckman Institute.